Compile Data Set for Download or QSAR
Report error Found 123 of affinity data for UniProtKB/TrEMBL: P41587
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50200209(CHEMBL219499)
Affinity DataEC50:  0.0870nMAssay Description:Activity at human VPAC2 receptor in CHO cells by measuring cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50200210(Ac-HSDAVFTDQYTRLRKQVAAKKYLQSIKQKRYC | CHEMBL440082)
Affinity DataEC50:  0.600nMAssay Description:Activity at human VPAC2 receptor in CHO cells by measuring cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445107(CHEMBL3102924)
Affinity DataEC50:  0.100nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445108(CHEMBL3102923)
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445109(CHEMBL3102922)
Affinity DataEC50:  0.210nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445110(CHEMBL3102921)
Affinity DataEC50:  0.380nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445111(CHEMBL3102920)
Affinity DataEC50:  6.60nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445112(CHEMBL3102919)
Affinity DataEC50:  0.140nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445113(CHEMBL1981592)
Affinity DataEC50:  0.190nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445114(CHEMBL3105020)
Affinity DataEC50:  0.390nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445115(CHEMBL3105019)
Affinity DataEC50:  1.5nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445116(CHEMBL3102931)
Affinity DataEC50:  0.330nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445117(CHEMBL3102930)
Affinity DataEC50:  0.0500nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445118(CHEMBL3102929)
Affinity DataEC50:  0.210nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445119(CHEMBL3102928)
Affinity DataEC50:  3.80nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445120(CHEMBL3102927)
Affinity DataEC50:  1.5nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445121(CHEMBL3102926)
Affinity DataEC50:  1.40nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50445122(CHEMBL3102925)
Affinity DataEC50:  0.110nMAssay Description:Agonist activity at human VPAC2 expressed in CHO Flp-in cells assessed as accumulation of cAMP after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2014
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50606527(CHEMBL5220770)
Affinity DataEC50:  0.0600nMAssay Description:Agonist activity at VPAC2 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50435130(CHEMBL1893324)
Affinity DataEC50:  0.0800nMAssay Description:Agonist activity at VPAC2 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50606528(CHEMBL5219662)
Affinity DataIC50: 4.5nMAssay Description:Antagonist activity at VPAC2 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50250018(PACAP27 | CHEMBL524852)
Affinity DataIC50: 10nMAssay Description:Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC2 expressed in CHO cells after 90 mins by gamma counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2020
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50200209(CHEMBL219499)
Affinity DataIC50: 13nMAssay Description:Displacement of [125I]PACAP27 from human VPAC2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50250074([Bip6]PACAP27 | CHEMBL507480)
Affinity DataIC50: 23nMAssay Description:Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC2 expressed in CHO cells after 90 mins by gamma counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2020
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50200210(Ac-HSDAVFTDQYTRLRKQVAAKKYLQSIKQKRYC | CHEMBL440082)
Affinity DataIC50: 27nMAssay Description:Displacement of [125I]PACAP27 from human VPAC2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/9/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50498951(CHEMBL3736134)
Affinity DataIC50: 36nMAssay Description:Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC2 expressed in CHO cells after 90 mins by gamma counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2020
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50498951(CHEMBL3736134)
Affinity DataIC50: 36nMAssay Description:Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC2 expressed in CHO cells after 90 mins by gamma counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2020
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50498950(CHEMBL3736230)
Affinity DataIC50: 53nMAssay Description:Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC2 expressed in CHO cells after 90 mins by gamma counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2020
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50498950(CHEMBL3736230)
Affinity DataIC50: 54nMAssay Description:Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC2 expressed in CHO cells after 90 mins by gamma counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/4/2020
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50393775(CHEMBL2159348)
Affinity DataIC50: 1.70E+3nMAssay Description:Antagonist activity at human VPAC2 expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50393788(CHEMBL2159347)
Affinity DataIC50: 2.60E+3nMAssay Description:Antagonist activity at human VPAC2 expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50393776(CHEMBL2159349)
Affinity DataIC50: 2.60E+3nMAssay Description:Antagonist activity at human VPAC2 expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50360601(CHEMBL1933349 | MK-0893)
Affinity DataIC50: 1.28E+4nMAssay Description:Antagonist activity at human VPAC2 expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM86050(Ac-L-His-L-Ser-L-Asp-L-Ala-L-Val-L-Phe-L-Thr-L-Glu...)
Affinity DataKi:  2.10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM81828(CAS_37221-79-7 | VIP(4-28) | Vasoactive intestinal...)
Affinity DataKi:  2.10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85873(VIP Ala2)
Affinity DataKi:  2.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85872(VIP Ala19)
Affinity DataKi:  2.40nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85872(VIP Ala19)
Affinity DataKi:  2.60nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85889(VIP Ala8)
Affinity DataKi:  2.70nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85871(VIP Ala9)
Affinity DataKi:  3.20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85873(VIP Ala2)
Affinity DataKi:  3.40nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85873(VIP Ala2)
Affinity DataKi:  3.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM86050(Ac-L-His-L-Ser-L-Asp-L-Ala-L-Val-L-Phe-L-Thr-L-Glu...)
Affinity DataKi:  3.90nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85886(VIP Ala24)
Affinity DataKi:  4.10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85871(VIP Ala9)
Affinity DataKi:  4.30nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85889(VIP Ala8)
Affinity DataKi:  4.40nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85879(VIP Ala16 | VIP Ala6)
Affinity DataKi:  4.70nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85872(VIP Ala19)
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM81828(CAS_37221-79-7 | VIP(4-28) | Vasoactive intestinal...)
Affinity DataKi:  5.30nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
TargetVasoactive intestinal polypeptide receptor 2(Human)
Bayer Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM85871(VIP Ala9)
In Depth
Date in BDB:
5/13/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 123 total ) | Next | Last >>
Jump to: